Monatshefte fur Chemie p. 801 - 824 (1981)
Update date:2022-08-11
Topics:
Neudeck, Horst
Schloegl, Karl
Starting from optically active 5,5'-dimethyl, diethyl, and 5-ethyl-5'-methyl-2,2'-spirobiindane as well as from 5'-ethyl-spirobiindane-5-carboxylic ester of known enantiomeric purity and configuration 75 mono to polysubstituted 2,2'-spirobiindanes have been prepared.Amongst these are several compounds with rings anellated in the 6,7 (and 6',7') positions, especially a spirohydrocarbon 4x with orthogonal naphthalene units the circular dichroism of which is reported and discussed.Several mono and disubstituted 5-methyl and ethylindanes (1, 2) have been prepared as models for synthetic transformations in the spirobiindane series.From the molar rotations of symmetrically diacylated 5,5'-dimethyl and diethyl spirobiindanes (4a, 7b, 7c) empirical ligand parameters λ for acetyl and methoxycarbonyl were determined which gave much better results in the calculation of the rotations of appropriate spirobiindanes (with the "shortened polynomal Ansatz") than the λ-values deduced previously from 5,5'-disubstituted spirobiindanes.The significance of these results is briefly discussed. - Keywords: Chirality function; Circular dichroism; Ligand parameters; 5-Methyl and ethylindanes; 1H-NMR spectra
View MoreWeifang Arylchem Chemical Co., LTD
Contact:86-536-5217866
Address:Development Zone, Shouguang, Shandong Province
Hunan Haili Chemical Industry Co.,Ltd.
Contact:+86-731-85521860
Address:No.251, 2nd Section, Furong Road, Changsha,Hunan,China
Weifang Dongxing Chitosan Factory
website:http://dxchitosan.lookchem.com/
Contact:13475651157
Address:Weifang city ,shandong province
Contact:+86 18616952870
Address:Area
Wuhan Yitongtai Science and Technology Co.,Ltd.
Contact:+86-27-88933550
Address:27th Fl. Bldg. 1, Shuian International Mansion, Heping Ave, Wuhan, Hubei, China
Doi:10.1002/1521-3773(20011203)40:23<4498::AID-ANIE4498>3.0.CO;2-3
(2001)Doi:10.1016/S0040-4039(98)00890-9
(1998)Doi:10.3390/molecules24244559
(2019)Doi:10.1021/jo01263a047
(1969)Doi:10.1021/jm8012618
(2009)Doi:10.1016/j.ijpharm.2020.119239
(2020)